Chemotherapy and Targeted Therapy

The Architects of the Digital Biome: Dimension Closes $800M Fund as AI-Drug Discovery Hits Inflection Point the-architects-of-the-digital-biome-dimension-closes-800m-fund-as-ai-drug-discovery-hits-inflection-point

The Architects of the Digital Biome: Dimension Closes $800M Fund as AI-Drug Discovery Hits Inflection Point

Lina Hope July 22, 2026

By Ben Fidler | July 21, 2026 In the high-stakes theater of modern venture capital, few firms...

The GLP-1 Paradigm Shift: How the Quest for New Indications is Transforming the Biospecimen Landscape the-glp-1-paradigm-shift-how-the-quest-for-new-indications-is-transforming-the-biospecimen-landscape

The GLP-1 Paradigm Shift: How the Quest for New Indications is Transforming the Biospecimen Landscape

Nana Wu July 22, 2026

In less than a decade, the therapeutic landscape of metabolic medicine has been fundamentally rewritten. What began...

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design Chemistry and Medical abstract blue background . 3d rendering

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design

Laily UPN July 22, 2026

In the fast-paced world of biotechnology, where artificial intelligence (AI) has become the industry’s favorite buzzword, a...

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis tempus-ai-bolsters-cancer-diagnostics-portfolio-with-strategic-acquisition-of-personalis

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis

Raul Delapena Setiawan July 22, 2026

By Elise Reuter Published July 20, 2026 In a move that signals a significant consolidation in the...

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin insuring-the-psychedelic-frontier-navigating-the-liability-landscape-of-fda-approved-psilocybin-1

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

Nana Wu July 22, 2026

For over half a century, psilocybin has languished in the shadow of the 1970 Controlled Substances Act,...

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims the-weight-loss-wars-novo-nordisk-escalates-legal-battle-against-eli-lilly-over-advertising-claims

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims

Laily UPN July 21, 2026

By Industry Desk July 21, 2026 The fierce rivalry between the two titans of the GLP-1 obesity...

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care weekly-hiv-treatment-breakthrough-gilead-and-mercks-oral-regimen-poised-to-transform-patient-care

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care

Ammar Sabilarrohman July 21, 2026

The landscape of HIV treatment is on the precipice of a significant paradigm shift. For decades, the...

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing the-billion-dollar-arms-race-bristol-myers-squibb-challenges-pharma-giants-with-next-gen-ai-supercomputing

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing

Ammar Sabilarrohman July 21, 2026

In a decisive move that underscores the escalating importance of artificial intelligence in drug discovery, Bristol Myers...

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains from-protocol-to-patient-decoding-the-high-stakes-world-of-clinical-supply-chains

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains

Pevita Pearce July 21, 2026

By BioPharma Dive Editorial Team Published July 20, 2026 The transition from a promising scientific discovery in...

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence beyond-the-hunch-why-rigorous-matching-is-the-new-gold-standard-in-real-world-evidence

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence

Dwi Wanna July 21, 2026

In the modern clinical landscape, the intersection of patient data and medical insight is becoming increasingly complex....

Chemotherapy and Targeted Therapy

The Architects of the Digital Biome: Dimension Closes $800M Fund as AI-Drug Discovery Hits Inflection Point

The GLP-1 Paradigm Shift: How the Quest for New Indications is Transforming the Biospecimen Landscape

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence

You may have missed

Ibuprofen: Beyond Pain Relief – Unveiling its Unexpected Anti-Cancer Potential

A Paradigm Shift in HIV Care: Gilead and Merck’s Once-Weekly Regimen Passes Phase 3 Milestone

Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

The Radiology Crisis: Escalating Costs and Workforce Shortages Threaten Patient Care